Compare Stocks: BEAT, ACHC, and BICX

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ACHC Acadia Healthcare	$30.60 +2.4%	$30.14	$11.43 ▼ $35.83	$2.85B	0.64	3.19 million shs	1.51 million shs
BEAT HeartBeam	$0.48 -4.8%	$0.59	$0.47 ▼ $4.00	$26.98M	-0.78	1.06 million shs	206,098 shs
BICX Biocorrx	$0.25 +12.1%	$0.30	$0.15 ▼ $1.28	$7.44M	0.19	7,219 shs	6,020 shs

7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ACHC Acadia Healthcare	+4.00%	+8.78%	-13.45%	+23.99%	+34.73%
BEAT HeartBeam	+4.10%	+4.77%	-1.70%	-42.52%	-54.89%
BICX Biocorrx	+0.01%	-7.07%	-25.66%	-41.15%	-36.28%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ACHC Acadia Healthcare	$30.60 +2.4%	$30.14	$11.43 ▼ $35.83	$2.85B	0.64	3.19 million shs	1.51 million shs
BEAT HeartBeam	$0.48 -4.8%	$0.59	$0.47 ▼ $4.00	$26.98M	-0.78	1.06 million shs	206,098 shs
BICX Biocorrx	$0.25 +12.1%	$0.30	$0.15 ▼ $1.28	$7.44M	0.19	7,219 shs	6,020 shs

7 Stocks That Could Lead the Next Market Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ACHC Acadia Healthcare	+4.00%	+8.78%	-13.45%	+23.99%	+34.73%
BEAT HeartBeam	+4.10%	+4.77%	-1.70%	-42.52%	-54.89%
BICX Biocorrx	+0.01%	-7.07%	-25.66%	-41.15%	-36.28%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ACHC Acadia Healthcare	2.47	Hold	$29.85	-3.82% Downside
BEAT HeartBeam	2.67	Moderate Buy	$4.00	729.36% Upside
BICX Biocorrx	2.00	Hold	N/A	N/A

Current Analyst Ratings Breakdown

Latest BEAT, ACHC, and BICX Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/30/2026	ACHC Acadia Healthcare	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$38.00 ➝ $39.00
7/30/2026	ACHC Acadia Healthcare	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Equal Weight	$25.00 ➝ $32.00
7/29/2026	ACHC Acadia Healthcare	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral
7/14/2026	ACHC Acadia Healthcare	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$30.00 ➝ $40.00
7/14/2026	ACHC Acadia Healthcare	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$30.00 ➝ $36.00
7/14/2026	BEAT HeartBeam	Maxim Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$2.00
7/9/2026	ACHC Acadia Healthcare	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$31.00 ➝ $39.00
7/2/2026	BEAT HeartBeam	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
6/12/2026	ACHC Acadia Healthcare	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D)
6/3/2026	ACHC Acadia Healthcare	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Buy	$24.50 ➝ $30.00
5/27/2026	ACHC Acadia Healthcare	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight	$30.00

(Data available from 8/26/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ACHC Acadia Healthcare	$3.37B	0.86	$4.41 per share	7.03	$21.26 per share	1.46
BEAT HeartBeam	N/A	N/A	N/A	N/A	$0.15 per share	N/A
BICX Biocorrx	$800K	9.30	N/A	N/A	($0.42) per share	-0.60

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ACHC Acadia Healthcare	-$1.10B	-$12.45	N/A	17.43	9.25	-33.44%	6.19%	2.42%	11/4/2026 (Estimated)
BEAT HeartBeam	-$21.01M	-$0.51	N/A	N/A	N/A	N/A	-686.78%	-348.65%	11/12/2026 (Estimated)
BICX Biocorrx	-$3.44M	-$0.12	N/A	N/A	N/A	N/A	N/A	-90.89%	N/A

Latest BEAT, ACHC, and BICX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/14/2026	Q2 2026	BICX Biocorrx	-$0.05	-$0.03	+$0.02	-$0.03	$0.24 million	$0.09 million
8/13/2026	Q2 2026	BEAT HeartBeam	-$0.0860	-$0.10	-$0.0140	-$0.10	$0.15 million	N/A
7/28/2026	Q2 2026	ACHC Acadia Healthcare	$0.3463	$0.38	+$0.0337	$0.12	$844.19 million	$865.84 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ACHC Acadia Healthcare	N/A	N/A	N/A	N/A	N/A
BEAT HeartBeam	N/A	N/A	N/A	N/A	N/A
BICX Biocorrx	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ACHC Acadia Healthcare	1.20	1.57	1.57
BEAT HeartBeam	N/A	3.66	3.61
BICX Biocorrx	N/A	0.07	0.07

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ACHC Acadia Healthcare	N/A
BEAT HeartBeam	7.77%
BICX Biocorrx	N/A

Insider Ownership

Company	Insider Ownership
ACHC Acadia Healthcare	1.20%
BEAT HeartBeam	17.95%
BICX Biocorrx	21.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ACHC Acadia Healthcare	25,000	93.10 million	91.98 million	Optionable
BEAT HeartBeam	1,700	56.35 million	46.23 million	Not Optionable
BICX Biocorrx	3	29.76 million	23.39 million	Not Optionable

BEAT, ACHC, and BICX Headlines

Recent News About These Companies

BioCorRx Announces National Drug Codes (NDCs) for LUCEMYRA (lofexidine) Brand and Authorized Generic (AG) SKUs to Ensure Uninterrupted Market Supply

August 25 at 1:06 PM | finance.yahoo.com

Biocorrx (OTCMKTS:BICX) Stock Price Passes Below Two Hundred Day Moving Average - Should You Sell?

August 22, 2026 | americanbankingnews.com

BioCorRx Inc.

April 21, 2026 | marketwatch.com

BioCorRx, Inc. Announces Issuance of U.S. Patent Supporting Its Biodegradable Naltrexone Implant Technology

March 11, 2026 | finance.yahoo.com

BioCorRx, Inc. Announces Initiation of Clinical Study by Majority-Owned Subsidiary BioCorRx Pharmaceuticals, Inc. Evaluating Long-Acting Naltrexone Implant With or Without ...

January 15, 2026 | finance.yahoo.com

EQS-News: BioCorRx Announces Appointment of Louis Lucido as Board Chair

January 6, 2026 | finanzen.atF

BioCorRx Announces Appointment of Louis Lucido as Board Chair

January 6, 2026 | finance.yahoo.com

BioCorRx Provides Update on OTC Markets Quotation Status and Planned Form S1 Filing

December 24, 2025 | finance.yahoo.com

BioCorRx Inc. to Present at the Life Sciences Virtual Investor Forum December 11th

December 10, 2025 | globenewswire.com

Diamond Equity Research Releases Update Note on BioCorRx®, Inc. (OTCQB: BICX)

November 19, 2025 | globenewswire.com

Diamond Equity Research Initiates Coverage on BioCorRx®, Inc. (OTCQB: BICX)

August 25, 2025 | globenewswire.com

BioCorRx Reports 3,985% Revenue Growth to $313K in the First Half of 2025 Driven by LUCEMYRA(R) (lofexidine) Sales

August 14, 2025 | finance.yahoo.com

BioCorRx Inc. (BICX) Latest Press Releases & Corporate News - Yahoo Finance

June 1, 2025 | finance.yahoo.com

BioCorRx Reports Business Update for the First Quarter of 2025

May 20, 2025 | finance.yahoo.com

BioCorRx Pharmaceuticals Inc. Announces That it has Acquired LUCEMYRA(R) (lofexidine), an FDA-Approved Opioid Withdrawal Medication, From USWM, LLC

March 10, 2025 | finance.yahoo.com

Naltrexone LA by BioCorRx for Alcohol Dependence: Likelihood of Approval

January 5, 2025 | pharmaceutical-technology.comP

La Rosa Holdings Corp. secures new financing, reshuffles leadership

October 6, 2024 | investing.com

BioCorRx Inc: BioCorRx Reports Business Update for the Second Quarter of 2024

August 16, 2024 | finanznachrichten.de

BioCorRx Reports Business Update for the Second Quarter of 2024

August 15, 2024 | globenewswire.com

Is Avalon Globocare Corp (ALBT) Stock a Good Investment?

August 2, 2024 | aaii.comA

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

BEAT, ACHC, and BICX Company Descriptions

Acadia Healthcare NASDAQ:ACHC

$30.60 +0.73 (+2.44%)

As of 03:33 PM Eastern

Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.

HeartBeam NASDAQ:BEAT

$0.48 -0.02 (-4.81%)

As of 03:26 PM Eastern

BioTelemetry, Inc., a remote medical technology company, provides remote cardiac monitoring, remote blood glucose monitoring, centralized core laboratory services for clinical trials, and original equipment manufacturing services for healthcare and clinical research customers worldwide. It operates in two segments, Healthcare and Research. The Healthcare segment focuses on the remote cardiac monitoring to identify cardiac arrhythmias or heart rhythm disorders. This segment offers mobile cardiac telemetry services; and event monitoring services, which enable physicians to prescribe wireless event, digital loop event, memory loop event, memory loop event, and non-loop event monitors. It also provides traditional and extended Holter, pacemaker, international normalized ratio, implantable loop recorder, and other implantable cardiac device monitoring services. It serves cardiologists, electrophysiologists, neurologists, and primary care physicians. The Research segment offers laboratory services, such as cardiac monitoring, imaging, scientific consulting, and data management services for drug and medical device trials. Its centralized services comprise electrocardiogram, Holter monitoring, ambulatory blood pressure monitoring, echocardiography, multigated acquisition scan, imaging, protocol development, expert reporting, and statistical analysis. It also provides support services, such as project coordination, setup and management, equipment rental, data transfer, processing, analysis, and 24/7 customer support and site training. The company also focuses on manufacturing, testing, and marketing of cardiac devices and blood glucose monitoring devices, as well as offers contract manufacturing services. BioTelemetry, Inc. was founded in 1994 and is headquartered in Malvern, Pennsylvania.

Biocorrx OTCMKTS:BICX

$0.25 +0.03 (+12.11%)

As of 09:30 AM Eastern

BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest BEAT, ACHC, and BICX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest BEAT, ACHC, and BICX Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

BEAT, ACHC, and BICX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

BEAT, ACHC, and BICX Company Descriptions

Acadia Healthcare NASDAQ:ACHC

HeartBeam NASDAQ:BEAT

Biocorrx OTCMKTS:BICX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest BEAT, ACHC, and BICX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest BEAT, ACHC, and BICX Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

BEAT, ACHC, and BICX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

BEAT, ACHC, and BICX Company Descriptions

Acadia Healthcare NASDAQ:ACHC

HeartBeam NASDAQ:BEAT

Biocorrx OTCMKTS:BICX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools